- Our investment strategy was absolutely perfect for MNKD (MannKind Corp)
- OREX doubles on FDA approval. We already had it!
- Ivy Investment Group continues to track OREX, raises forecast
- Our stock pick OREX snatches 8% for the week!
- It takes CNN money almost 2 weeks to catch up with Ivy Investment Group's forecast
INSTAPOSTS more »